Gijs Aertssen: New Evidence on Joint Prosthesis Survival in Inherited Bleeding Disorders
Gijs Aertssen, PHD Candidate at UMC Utrecht, shared on LinkedIn about a recent article he and his colleagues co-authored published in RPTH, adding:
“We present exciting findings on prosthesis survival in people with bleeding disorders: long-term prosthesis survival (up to 25 years) is comparable to that of the general population.
After presenting these results at the EAHAD Congress in Dublin last February, we are pleased to publish the full manuscript in Research and Practice in Thrombosis and Haemostasis (RPTH).”
Title: Long-term prosthesis survival of total hip and total knee arthroplasty in people with inherited bleeding disorders
Authors: Gijs Aertssen, Huub M. de Visser, Wouter Foppen, Roger E. G. Schutgens, Merel A. Timmer, Lize F. D. van Vulpen

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks